**Core Concept:** Radiosensitizers are drugs that increase the effectiveness of radiation therapy by enhancing the DNA damage in cancer cells, thereby improving the treatment outcome. These drugs are often used in conjunction with radiotherapy for cancer treatment.

**Why the Correct Answer is Right:** Platinum-based compounds are a class of radiosensitizing drugs commonly used in cancer therapy, including head and neck surgery. One such compound is Cisplatin (Dactinomycin), which is an anticancer drug that works by forming intra- and inter-strand crosslinks in DNA, leading to cell cycle arrest and apoptosis.

**Why Each Wrong Option is Incorrect:**

A. **Option A (Dactinomycin):** Although Dactinomycin is an anti-cancer drug, it is not a radiosensitizer. It primarily functions as a DNA alkylating agent, inhibiting DNA synthesis and repair.

B. **Option B (5-fluorouracil):** 5-Fluorouracil is a cytotoxic drug, which inhibits DNA, RNA, and protein synthesis, not a radiosensitizer. It is primarily used in combination with chemotherapy for various cancers.

C. **Option C (Methotrexate):** Methotrexate is an antifolate drug, primarily used as an antineoplastic agent. It inhibits dihydrofolate reductase, leading to impaired purine and pyrimidine synthesis. However, it is not a radiosensitizer.

D. **Option D (Cisplatin):** As mentioned earlier, Cisplatin is an anti-cancer drug that inhibits DNA synthesis and repair, not a radiosensitizer.

**Clinical Pearl:** In head and neck cancer treatment, the choice of radiosensitizer depends on the specific cancer type and patient factors. Consulting a medical oncologist is essential to determine the most effective radiosensitizer for a given case.

**Correct Answer:** Cisplatin (Option D) is a platinum-based compound that functions as an anti-cancer drug. When used in combination with radiation therapy, it enhances the effectiveness of radiation in killing cancer cells, making it a radiosensitizer drug.